EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access

The Optimal Dosage and Duration of Metformin for Prevention and Treatment of Antipsychotic-Induced Weight Gain: An Updated Systematic Review and Meta-Analysis

Tzu-Rong Peng iD, Jou-An Chen, Jen-Ai Lee, Chih-Pin Hsing, Ming-Chia Lee, Shih-Ming Chen

Schizophrenia Bulletin · 08.05.2025 · 51 (3) · 625-636

DOI: 10.1093/schbul/sbae173 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Schizophrenia Bulletin, online erschienen am 07.11.2024. Verfasst von Tzu-Rong Peng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231016, Taiwan. Hauptthemen laut MEDLINE: Metformin, Weight Gain, Antipsychotic Agents, Schizophrenia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Weight gain and metabolic complications are substantial adverse effects associated with second-generation antipsychotics. However, comprehensive guidelines for managing antipsychotic-induced weight gain are lacking.

Methods

This review included all double-blind, placebo-controlled studies investigating metformin’s effectiveness in addressing antipsychotic-related weight gain. We systematically searched PubMed, Embase, the Cochrane Central Register of Controlled Trials, Google Scholar, and ClinicalTrials.gov for relevant studies from the inception to 2024. A random-effects model was used for the meta-analysis.

Results

This meta-analysis, including 20 studies with 1070 patients, revealed that metformin significantly surpassed placebo in attenuating weight gain in patients receiving antipsychotics. The mean weight change with metformin was −3.32 kg [95% confidence interval (CI): −4.57 to −2.07]. Additionally, metformin use resulted in a marked decrease in body mass index [−1.24 kg/m2 (95% CI: −1.70 to −0.77)]. Metformin could maintain the effects from 12 to 24 weeks.

Conclusions

This updated meta-analysis investigated the durations and dosages of metformin use in patients with schizophrenia experiencing antipsychotic-induced weight gain. The findings highlight the need for additional large-scale research to validate our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminWeight GainAntipsychotic AgentsSchizophreniaHypoglycemic AgentsHumans

Stichwörter der Autor:innen

antipsychotic-induced weight gainmeta-analysismetformin

Substanzen

MetforminAntipsychotic AgentsHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231016, Taiwan.
  • School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
  • Graduate Institute of Counseling Psychology and Rehabilitation Counseling, National Kaohsiung Normal University, Kaohsiung 80201, Taiwan.
  • Department of Pharmacy, New Taipei City Hospital, New Taipei City 24141, Taiwan.
  • Department of Nursing, Cardinal Tien College of Healthcare and Management, New Taipei City 231038, Taiwan.

ORCID-Profile: Tzu-Rong Peng

Zitieren

APA

Peng, T. R., Chen, J. A., Lee, J. A., Hsing, C. P., Lee, M. C., & Chen, S. M. (2025). The Optimal Dosage and Duration of Metformin for Prevention and Treatment of Antipsychotic-Induced Weight Gain: An Updated Systematic Review and Meta-Analysis. Schizophrenia Bulletin, 51(3), 625-636. https://doi.org/10.1093/schbul/sbae173

Vancouver

Peng TR, Chen JA, Lee JA, Hsing CP, Lee MC, Chen SM. The Optimal Dosage and Duration of Metformin for Prevention and Treatment of Antipsychotic-Induced Weight Gain: An Updated Systematic Review and Meta-Analysis. Schizophrenia Bulletin. 2025;51(3):625-636. doi:10.1093/schbul/sbae173

BibTeX
@article{Peng2025,
  author = {Peng, Tzu-Rong and Chen, Jou-An and Lee, Jen-Ai and Hsing, Chih-Pin and Lee, Ming-Chia and Chen, Shih-Ming},
  title = {The Optimal Dosage and Duration of Metformin for Prevention and Treatment of Antipsychotic-Induced Weight Gain: An Updated Systematic Review and Meta-Analysis},
  journal = {Schizophrenia Bulletin},
  year = {2025},
  volume = {51},
  number = {3},
  pages = {625--636},
  doi = {10.1093/schbul/sbae173}
}
Kostenlos starten →